Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter?

Drug and Alcohol Dependence

Volumn 173, Issue , 2017, Pages S4-S10

  Cicero, Theodore J ^a   Ellis, Matthew S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Iatrogenic abuse; Opioid abuse; Opioids; Pharmacoepidemiology; Psychiatric epidemiology

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; EUPHORIA; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OPIATE ADDICTION; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; SELF MEDICATION; STRUCTURED INTERVIEW; WITHDRAWAL SYNDROME; AGE; EPIDEMIC; MENTAL DISORDERS; MIDDLE AGED; MOTIVATION; OPIOID-RELATED DISORDERS; PAIN; PHARMACOEPIDEMIOLOGY; PSYCHOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADULT; AGE FACTORS; ANALGESICS, OPIOID; COMORBIDITY; EPIDEMICS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MOTIVATION; OPIOID-RELATED DISORDERS; PAIN; PHARMACOEPIDEMIOLOGY; PRESCRIPTION DRUGS; RISK FACTORS; SELF MEDICATION; YOUNG ADULT;

EID: 85026306586     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.03.014     Document Type: Article

References (31)

1. Adams, E.H., Breiner, S., Cicero, T.J., Geller, A., Inciardi, J.A., Schnoll, S.H., Senay, E.C., Woody, G.E., A comparison of the abuse liability of tramadol NSAIDs, and hydrocodone in patients with chronic pain. J. Pain Symptom Manage. 31 (2006), 465–476.
2. Baumeister, R.F., Vonasch, A.J., Use of self-regulation to facilitate and restrain addictive behavior. Addict. Behav. 44 (2014), 3–8.
3. Beauchamp, G.A., Winstanley, E.L., Ryan, S.A., Lyons, M.S., Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am. J. Public Health 104 (2014), 2023–2029.
4. Boettke, P.J., Coyne, C.J., Hall, A.R., Keep off the grass: the economics of prohibition and US drug policy. Oregon Law Rev. 91 (2013), 1069–1096.
5. Bohnert, A.S., Eisenberg, A., Whiteside, L., Price, A., McCabe, S.E., Ilgen, M.A., Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. Addict. Behav. 38 (2013), 1776–1781.
6. Boyles S., CDC: Alarming increase in methadone deaths. Deaths from opioid painkillers have tripled since 1999. WebMD Health News. September, 30, 2009.
7. Cai, R., Crane, E., Poneleit, K., Paulozzi, L., Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004–2008. J. Pain Palliat. Care Pharmacother. 24 (2010), 293–297.
8. ®). Pain Med. 8 (2007), 157–170.
9. Cicero, T.J., Ellis, M.S., Harney, J., Shifting patterns of prescription opioid and heroin abuse in the United States. N. Engl. J. Med. 373 (2015), 1789–1790.
10. Dart, R.C., Surratt, H.L., Cicero, T.J., Parrino, M.W., Severtson, G., Bucher-Bartelson, B., Green, J.L., Trends in opioid analgesic abuse and mortality in the United States. N. Engl. J. Med. 372 (2015), 241–248.
11. Foodand Drug Administration, Guidance For Industry: Abuse-Deterrent Opioids—Evaluation And Labeling. 2013 at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM334743.pdf. (accessed 01.12.15).
12. Fowler, C.D., Kenny, P.J., Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability. Neuropharmacology 76 (2014), 533–544 (Pt. B).
13. Goldner, E.M., Lusted, A., Roerecke, M., Rehm, J., Fischer, B., Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addict. Behav. 39 (2014), 520–531.
14. Hall, D.H., Queener, J.E., Self-medication hypothesis of substance abuse: testing Khantzian's updated theory. J. Psychoact. Drugs 39 (2007), 151–158.
15. Kato, K., Sullivan, P.F., Evengård, B., Pedersen, N.L., Chronic widespread pain and its comorbidities: a population-based study. Arch. Intern. Med. 166 (2006), 1649–1654.
16. Khantzian, E.J., The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 142 (1985), 1259–1264.
17. Lembke, A., Time to abandon the self-medication hypothesis in patients with psychiatric disorders. Am. J. Drug Alcohol Abuse 38 (2012), 524–529.
18. Manchikanti, L., Fellows, B., Ailinani, H., Pampati, V., Therapuetic use, abuse and nonmedical use of opioids: a ten-year perspective. Pain Physician 13 (2010), 401–435.
19. McCabe, S.E., Cranford, J.A., Motivational subtypes of nonmedical use of prescription medications: results from a national study. J. Adolesc. Health 51 (2012), 445–452.
20. McCabe, S.E., Cranford, J.A., West, B.T., Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict. Behav. 33 (2008), 1297–1305.
21. McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Argeriou, M., The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 9 (1992), 199–213.
22. Reifler, L.M., Droz, D., Bailey, J.E., Schnoll, S.H., Fant, R., Dart, R.C., Bucher Bartelson, B., Do prescription monitoring programs impact state trends in opioid abuse/misuse?. Pain Med. 13 (2012), 434–442.
23. Rogers, P.D., Copley, L., The nonmedical use of prescription drugs by adolescents. Adolesc. Med. State Art. Rev. 20 (2009), 1–8 (vii).
24. Schulden, J.D., Thomas, Y.F., Compton, W.M., Substance abuse in the United States: findings from recent epidemiologic studies. Curr. Psychiatry Rep. 5 (2009), 353–359.
25. Silva, K., Kecojevic, A., Lankenau, S.E., Perceived drug use functions and risk reduction practices among high-risk nonmedical users of prescription opioids. J. Drug Issues 43 (2013), 483–496.
26. Skurtveit, S., Furu, K., Selmer, R., Handal, M., Tverdal, A., Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study. Ann. Epidemiol. 20 (2010), 890–897.
27. Substance Abuse and Mental Health Services Administration, 2013, Results from the 2012 National Survey on Drug Use and Health: Summary of national findings. NSDUH Series H-46, HHS Publication No. 13–4795. Rockville, MD.
28. The White House, Office of the Press Secretary,. FACT SHEET: Obama Administration Announces Public and Private Sector Efforts to Address Prescription Drug Abuse and Heroin Use. October 21, 2015. 2015 at https://www. whitehouse. gov/the-press-office/2015/10 /21/fact-sheet-obama-administration-announces-public-and-private-sector. (accessed 01.12.15).
29. Turk, D.C., Audette, J., Levy, R.M., Mackey, S.C., Stanos, S., Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo Clin. Proc. 85 (2010), S42–S50.
30. Wasan, A.D., Michna, E., Edwards, R.R., Katz, J.N., Nedeljkovic, S.S., Dolman, A.J., Janfaza, D., Isaac, Z., Jamison, R.N., psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain. Anesthesiology 123 (2015), 861–872.
31. Zacny, J.P., Lichtor, S.A., Nonmedical use of prescription opioids: motive and ubiquity issues. J. Pain 9 (2008), 473–486.